Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 8,581-8,592 of 23,847
Drug study icon
WithdrawnNCT02418702

A Study to Decrease Suicidal Thinking Using Ketamine

This summary needs review. Please check the official study record and contact the research team for details.

In San Diego
DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
United States Naval Medical Center, San Diego
Condition
Depression
Drug study icon
CompletedNCT00212797

2 Doses of Org 34517 for depression

This study is completed. It is testing 2 Doses of Org 34517 for depression.

Location not clearly listed
Depression, SchizophreniaDrugFrom 18 Years to 70 Years
Countries
Sponsor
Merck Sharp & Dohme LLC
Condition
Depression, Schizophrenia
Drug study icon
CompletedNCT00880217

3 Different Doses of JNJ-31001074 for ADHD

This study is completed in the United States. It is testing 3 Different Doses of JNJ-31001074 for ADHD.

Multiple locations, including Little Rock
ADHDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
ADHD
Drug study icon
CompletedNCT01655680

ABT-126 for schizophrenia

This study is completed in the United States, in the United Kingdom, and in Russia. It is testing ABT-126 for schizophrenia.

Multiple locations, including Anaheim
SchizophreniaDrugFrom 20 Years to 65 Years
Countries
United States, United Kingdom, Russia
Sponsor
AbbVie (prior sponsor, Abbott)
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.